Development and Validation of an Autophagy-Stroma-Based Microenvironment Gene Signature for Risk Stratification in Colorectal Cancer

DOI: https://doi.org/10.2147/OTT.S312003
IF: 4
2021-05-31
OncoTargets and Therapy
Abstract:Lin Chen, * Kunzi Zhang, * Jian Sun, Jingtong Tang, Jianping Zhou Department of gastrointestinal surgery of the First Hospital of China Medical University, Shenyang, 110001, People's Republic of China *These authors contributed equally to this work Correspondence: Jianping Zhou Tel +8613840509519 Email Background: Colorectal cancer is the fourth most common cancer and the second leading cause of cancer-related death in the USA. The aim of this study was to establish a tumor gene signature based on tumor stromal cell and autophagy for predicting the risk of recurrence in patients with colorectal cancer. Methods: We used "Rtsne" and "xCell" R packages to estimate autophagy and stroma status, respectively. The discovery cohort used microarray gene expression data retrieved from the GSE39582 dataset. The Cox regression model and Least Absolute Shrinkage and Selection Operator (LASSO) were used to identify prognostic genes and to construct an autophagy-stroma-based gene signature. Moreover, external validation was conducted using GSE17538, GSE38832, TCGA database, and patient data obtained from the First Hospital of China Medical University (CMU). Results: The LASSO model identified three genes ( TNS1, TAGLN , and SFRP4 ) which were used to develop a risk stratification gene signature. The autophagy-stroma-based gene signature was identified as an independent prognostic factor by multivariate analysis (p = 0.0023). The results were validated in GSE17538 (p=0.0062), GSE38832 (p=0.028), TCGA (p=0.046) database, and patient data obtained from the First Hospital of China Medical University (CMU) (p=0.027). Conclusion: We have established and verified a feasible prognostic model of colorectal cancer based on autophagy and stromal cell characteristics of patients. The model can be used to evaluate recurrence risk of cancer patients, and the hub genes in the model provide potential targets for targeted colorectal cancer treatment. Keywords: autophagy, stroma, tumor microenvironment, colorectal cancer, TNS1, TAGLN, SFRP4 Colorectal cancer (CRC) is the fourth most common cancer (8.2% of all new cancer cases) and the second leading cause of cancer-related death (8.8% of all cancer deaths) in the USA. 1 However, its incidence varies widely from region to region. CRC can be regarded as a sign of socio-economic development because its incidence rate tends to rise consistently with increase of the human development index. 2 Therefore, it is foreseeable that its incidence will increase significantly with further development of the global economic situation. It is worth noting that the 5-year relative survival rate for colorectal cancer patients is 65%. A previous study reported that the incidence rate of patients diagnosed with stage I or stage II CRC accounted for 20% and 22%, respectively, and the 5-year relative survival rates were 91% and 82%, respectively. However, the 5-year survival rate for stage IV CRC decreases to 12%. 3 In recent years, the tumor microenvironment has become increasingly important to researchers. Studies have shown that the tumor microenvironment of CRC is a key factor affecting the prognosis of colorectal cancer, 4 , 5 and holds keys to future cancer therapy. 6 Generally, colorectal tumors are rich in stroma. 7 Previous studies have reported that stromal cells are differentially expressed in CRC tissues and adjacent tissues, 8 and affect the occurrence of colorectal cancer. 9 Notably, stromal cells affect the prognosis of CRC patients by affecting the tumor microenvironment. 10 On the other hand, the role of autophagy in tumors is controversial. Some researchers believe that autophagy can promote the occurrence and development of colorectal cancer. 11–13 However, a recent study by Nassour et al 14 reported that autophagy has an inhibitory effect on cancer. For example, one study has shown that autophagy can inhibit the occurrence and development of colorectal cancer. 15 Interestingly, accumulating evidence indicates that there is a direct or indirect interaction between stromal cells and autophagy in the tumor microenvironment. 16 , 17 In this study, we speculate that the interaction between autophagy and stromal cells can provide prognostic value for patients with colorectal cancer. There -Abstract Truncated-
oncology,biotechnology & applied microbiology
What problem does this paper attempt to address?